NCT04767750
- Conditions
- Adenocarcinoma, Cancer, Carcinoma, +18 more
- Locations
-
- Gastroenterology Center, Mansoura University Al Mansurah, Dakahliya, Egypt
- Specialized Medical Hospital, Mansoura University Al Mansurah, Dakahliya, Egypt
Clinical trial condition
Hepatocellular Carcinoma
Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
1,013 public trials
265 recruiting studies
Hepatocellular Carcinoma trial results
NCT04659005
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +18 more
- Locations
-
- Henan Provincial People's Hospital Zhengzhou, Henan, China
- The Nethersole School of Nursing, The Chinese University of Hong Kong Hong Kong, China
NCT01340105
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Prince of Wales Hospital Hong Kong, China
NCT03259581
- Conditions
- Adenocarcinoma, Bilirubinemia, Carcinoma, +13 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
NCT01759901
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- The Prince of Wales Hospital Hong Kong, China
NCT01512407
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Prince of Wales Hospital Hong Kong, China
NCT05281783
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Interventional Ultrasonography Unit, Tropical Medicine Department, Beni-Suef University Hospitals Banī Suwayf, Egypt
NCT02785835
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +32 more
- Locations
-
- Hospital de Orihuela Orihuela, Alicante, Spain
- Hospital Clínico Universitario de San Juan Sant Joan d'Alacant, Alicante, Spain
- Hospital Marina Baixa Villajoyosa, Alicante, Spain
- Hospital German Trias i Pujol Badalona, Barcelona, Spain
NCT02178358
- Conditions
- Adenocarcinoma, Bone Diseases, Bone Diseases, Developmental, +16 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bengbu, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
NCT03884751
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
- The 81st Hospital of Chinese PLA Nanjing, Jiangsu, China
- Renji Hospital Shang Hai Jiaotong Unversity of Medicine Shanghai, Shanghai Municipality, China